1 - Contact Lens Spectrum

Document technical information

Format doc
Size 29.7 kB
First found May 22, 2018

Document content analysis

Category Also themed
Language
Type
not defined
Concepts
no text concepts found

Persons

Organizations

Places

Transcript

Contact Lens Spectrum
May 2002
Document #82
References
(p. 25) No-fee Continuing Education: Medications and Contact Lens Wear, by Joel A.
Silbert, OD, FAAO
1. Miller D. Pharmaceutic agents and contact lens wear. Contact Lens Spectrum
10(2):44-52, 1995.
2. Bartlett JD: Medications and Contact Lens Wear. p.444. In: Silbert JA (ed): Anterior
Segment Complications of Contact Lens Wear, 2nd ed. Boston: ButterworthHeinemann, 2000.
3. Lowther GE. Contact lens solutions in clinical practice. p.379. In Bartlett JD and
Jaanus SD (eds): Clinical Ocular Pharmacology, 2nd ed. Boston: ButterworthHeinemann, 1989.
4. Podos SM, Becker B, Asseff C, et al: Pilocarpine therapy with soft contact lenses.
Am J Ophthalmol 73:336, 1972.
5. Fraunfelder FT, Hanna C. Ophthalmic drug delivery systems. Surv. Ophthalmol.
18:292, 1974.
6. Jain MR. Drug delivery through soft contact lenses. Br J Ophthalmol 72:150, 1988.
7. Ruben M, Watkins R. Pilocarpine dispensation for the soft hydrophilic contact lens.
Br J Ophthalmol 59:455, 1975.
8. Busin M, Spitznas M. Sustained gentamicin release by presoaked medicated bandage
contact lenses. Ophthalmology 95:796, 1988.
9. Marmion VJ, Jain MR. Role of soft contact lenses and delivery of drugs. Trans.
Ophthalmol Soc UK 96:319, 1976.
10. Krejci L, Brettschneider I, Praies R. Hydrophilic gel contact lenses as a new drug
delivery system in ophthalmology and as a therapeutic bandage lens. Acta Univ
Carol (Med) 21:387, 1975.
11. Shaw EL, Gasset AR. Management of an unusual case of keratitis mucosa with
hydrophilic contact lenses and N-acetylcysteine. Ann Ophthalmol 6:1054, 1974.
12. Wilson M, Leigh E. Therapeutic use of soft contact lenses. Proc R Soc Med 68:55,
1975.
13. Lemp MA. Bandage lenses and the use of topical solutions containing preservatives.
Ann Ophthalmol 10:1319, 1978.
14. Aquavella JV. New aspects of contact lenses in ophthalmology. Adv Ophthalmol
32:2, 1976.
15. Waltman SR, Kaufman HE. Use of hydrophilic contact lenses to increase ocular
penetration of topical drugs. Invest Ophthalmol Vis Sci 9:250, 1970.
16. Lowther GE. Preparations used with contact lenses. p.339. In Bartlett JD, Jaanus SD
(eds): Clinical Ocular Pharmacology (2nd ed). Boston: Butterworth-Heinemann,
1989.
17. Winder AP, Astbury NJ, Sheraideh GAK, et al. Penetration of mercury from
ophthalmic preservatives into the human eye. Lancet 2:237, 1980.
18. Silbert JA. A review of therapeutic agents and contact lens wear. J Am Optom Assoc
67(3):165-172, 1996.
19. Mahmood MA, Pillai S. Epinephrine staining of soft contact lenses. Arch
Ophthalmol 105:1021, 1987.
20. Miller D, Brooks S, Mobilia E. Adrenochrome staining of soft contact lenses. Ann
Ophthalmol 6:65, 1976.
21. Jaanus SD, Pagano VT, Bartlett JD. Drugs affecting the autonomic nervous system.
p.78. In Bartlett JD and Jaanus SD (eds): Clinical Ocular Pharmacology (2nd ed).
Boston: Butterworth-Heinemann, 1989.
22. Wartman RH. Contact lens related side-effects of systemic drugs. Contact Lens
Forum 12:42, 1987.
23. Messmer E, Font RL, Sheldon G, et al. Pigmented conjunctival cysts following
tetracycline/minocycline therapy. Ophthalmology 90:1462, 1983.
24. Lyons RW. Orange contact lenses from rifampin. N Engl J Med 300:372, 1979.
25. Fraunfelder FT. Orange tears. Am J Ophthalmol 89:752, 1980.
26. Meyer SM, Fraunfelder FT. Phenylephrine hydrochloride. Ophthalmology 87:1177,
1980.
27. Bartlett JD. Medications and contact lens wear. p.476. In Bartlett JD and Jaanus SD
(eds): Clinical Ocular Pharmacology (2nd ed). Boston: Butterworth-Heinemann,
1989.
28. Hurwitz P, Thompson JM. Use of naphazoline (privine) in ophthalmology. Arch
Ophthalmol 43:712, 1950.
29. Menger HC. New ophthalmic decongestant, tetrahydrozoline hydrochloride. JAMA
170:178, 1958.
30. Allansmith MR. Immunology of the external ocular tissues. J Am Optom Assoc
61(suppl):S16, 1990.
31. Felius K, van Bjisterveld OP. Effect of sodium cromoglycate on tear film breakup time. Ann Ophthalmol 17:80, 1987.
32. Iwasaki W, Kosaka Y, Momose T, et al. Absorption of topical disodium
cromoglycate and its preservatives by soft contact lenses. CLAO J 14:155, 1988.
33. Bartlett JD, Howes JF, Ghormley NR, et al: Safety and efficacy of loteprednol
etabonate for treatment of papillae in contact lens-associated giant papillary
conjunctivitis. Curr Eye Res 12:313, 1993.
34. Friedlaender MH, Howes J: A double-masked, placebo-controlled evaluation of the
efficacy and safety of loteprednol etabonate in the treatment of giant papillary
conjunctivitis. Am J Ophthalmol 123:455, 1997.
35. Asbell P, Howes J: A double-masked, placebo-controlled evaluation of the efficacy
and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis.
CLAO J 23:31, 1997.
(p. 34) Managing Silicone Hydrogel Complications, by Renée du Toit, Dip Optom,
MPhil, Deborah Sweeney, B Optom, PhD, Desmond Fonn, Dip Optom, MOptom, and
Judith Stern
1. Bergmanson JPG: Contact lens induced epithelial pathology. In Clinical Contact Lens
Practice (eds ES Bennett, BA Weissman, Chapter 60, Philadelphia, LB Lippincott
Company, 1992
2. Cockington CD, Hyndiuk RA. Bacterial keratitis. In: Tabbara K, Hyndiuk R, eds.
Infections in the eye. Second ed. Boston, USA: Little, Brown & Co., 323-347, 1996
3. Covey M, Sweeney DF, Terry R, Sankaridurg PR, Holden BA: Hypoxic effects of
high Dk soft contact lens wearers are negligible. Optom Vis Sci 78: 95-99, 2001
4. Dumbleton K, Chalmers RL, Richter DB, Fonn DB: Vascular response to extended
wear of hydrogel lenses with high and low oxygen permeability. Optom Vis Sci 78:
147-151, 2000
5. Fonn D, Du Toit R, Simpson TL, Vega JA, Situ P, Chalmers RL: Sympathetic
swelling response of the control eye to soft lenses in the other eye. Invest Ophthalmol
Vis Sci 40: 3116-3121, 1999
6. Papas EB, Vajdic CM, Austen R, Holden BA: High oxygen transmissibility soft
contact lenses do not induce limbal hyperaemia. Curr Eye Res 16: 942-948, 1997
7. Ren DH, Yamamoto K, Ladage PM, Molai M, Li L, Petroll WM, Jester JV,
Cavanagh HD. Adaptive effects of 30-night wear of hyper-O(2) transmissible contact
lenses on bacterial binding and corneal epithelium: a 1-year clinical trial.
Ophthalmology109(1):27-39, 2002
8. Smith A, Pennefather PM, Kaye SB, Hart CA. Fluoroquinolones: place in ocular
therapy. Drugs 61(6):747-61, 2001
(p. 42) Comparing RGP Multifocal Lens Designs, by Andreas Allmoslechner, MCOptom,
MS, FAAO
1. Muckenhirn D. Festlegung der Trennungslinien bei bifokalen Kontaktlinsen, Part 1.
Deutsche Optiker Zeitung. 11:89-99, 1989.
2. Muckenhirn D. Festlegung der Trennungslinien bei bifokalen Kontaktlinsen, Part 2.
Deutsche Optiker Zeitung. 12:101-106, 1989.

Similar documents

×

Report this document